The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
Livongo
Teladoc closes $18.5B Livongo buy
Teladoc (NYSE:TDOC) has closed its $18.5 billion purchase of Livongo Health (NSDQ:LVGO) ahead of schedule. The companies entered into a definitive merger agreement in August and closed the deal Oct. 30. Under the terms of the merger, Livongo shareholders will receive 0.5920 shares of Teladoc Health plus cash of $11.33 for each Livongo share, including a special […]
Livongo slides on Street-beating Q3 results
Livongo Health (NSDQ:LVGO) reported third-quarter results today that beat the consensus on Wall Street. The Mountain View, Calif.-based company reported losses of -$25.5 million, or -26¢ per share, on sales of $106.1 million for the three months ended Sept. 30, for a sales growth of 126.4% compared with Q3 2019. Adjusted to exclude one-time items, earnings […]
Livongo, Teladoc divulge more details of proposed $18.5M merger
Teladoc (NYSE:TDOC) and Livongo Health (NSDQ:LVGO) today filed a joint proxy statement in connection with a proposed merger. Last month, the companies entered into a definitive merger agreement worth approximately $18.5 million. At the time, each share of Livongo was set to be exchanged for 0.5920 shares of Teladoc, plus cash consideration of $11.33 per Livongo share, […]
MedTech 100 roundup: Up-and-down week for industry
Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]
Livongo slides despite Street-beating Q2
Livongo Health (NSDQ:LVGO) shares took a hit today on second-quarter results that came in ahead of the consensus forecast. The Mountain View, Calif.-based company posted losses of -$1.6 million, or -2¢ per share, on sales of $91.9 million for the three months ended June 30, 2020, for an 88% bottom-line gain while more than doubling its […]
MedTech 100 roundup: Another high as stocks tick up
For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Teladoc to acquire Livongo for $18.5B
Teladoc (NYSE:TDOC) announced today that it entered into a definitive merger agreement with Livongo Health (NSDQ:LVGO) worth $18.5 billion. Purchase, N.Y.-based Teladoc and Mountain View, Calif.-based Livongo are setting out to improve the delivery, access and experience of healthcare around the world by offering high-quality, technology-enabled longitudinal care, according to a news release. Under the agreement, […]
Livongo announces $400m offering
Livongo Health (NSDQ:LVGO) announced that it intends to offer $400 million in a private offering of convertible senior notes. Mountain View, Calif.-based Livongo also plans to grant the initial purchasers of the notes, due in 2025, a 13-day option to purchase up to an additional $60 million, according to a news release. The notes will be […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Livongo beats The Street in Q4 results
Livongo Health (NSDQ:LVGO) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mountain View, Calif.-based company reported losses of -$6 million, or -6¢ per share, on sales of $50.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 137.5% compared with Q4 2018. Adjusted to […]